ethylisopropylamiloride has been researched along with Infarction, Middle Cerebral Artery in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a rat transient middle cerebral artery occlusion model, intravenous infusion of SM-20220 reduced cerebral infarction when the serum concentration of SM- 20220 was maintained at about 10(-7) mol/l." | 1.31 | The Na(+)/H(+) exchanger SM-20220 attenuates ischemic injury in in vitro and in vivo models. ( Horikawa, N; Itoh, N; Kuribayashi, Y; Matsui, K; Nishioka, M; Ohashi, N, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horikawa, N | 1 |
| Nishioka, M | 1 |
| Itoh, N | 1 |
| Kuribayashi, Y | 1 |
| Matsui, K | 1 |
| Ohashi, N | 1 |
1 other study available for ethylisopropylamiloride and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
The Na(+)/H(+) exchanger SM-20220 attenuates ischemic injury in in vitro and in vivo models.
Topics: Amides; Amiloride; Animals; Brain Ischemia; Cell Hypoxia; Cells, Cultured; Cerebral Cortex; Dose-Res | 2001 |